Data as of Q4 2025 (Dec 31, 2025)

Argyle Capital Management, LLC

โ€ขCIK: 1321194โ€ขFiling: Q4 2025

**Argyle Capital Management Inc.** manages $300M across a diversified portfolio of 137 positions. The firm maintains significant exposure to technology and healthcare leaders, highlighted by a $13.1M stake in Microsoft (MSFT) and $11.9M in Eli Lilly (LLY). Other key allocations include $9.5M in JPMorgan Chase (JPM) and $8.8M in Merck (MCK). This concentration suggests a tactical focus on established mega-cap names across defensive and growth sectors.

Total AUM
$299.5M
QoQ Performance
+3.6%
Positions
137
Top 10 Concentration
28.2%
Latest Filing
Q4 2025

Top Holdings Allocation

MSFT4.4%
LLY4.0%
JPM3.2%
MCK2.9%
RTX2.5%
PNC2.4%
IBM2.3%
MRK2.2%

๐Ÿ“ˆ Biggest Buys

Q
Qnity Electronics Inc
NEW
0.4% of portfolio
APD
Air Products & Chem
+40.4%
0.6% of portfolio
MRK
Merck & Co Inc
+6.1%
2.2% of portfolio
FOUR
Shift4 Pmts Inc
+37.5%
0.4% of portfolio
DOW
Dow Inc
+22.8%
0.6% of portfolio

๐Ÿ“‰ Biggest Sells

CAT
Caterpillar Inc Del
-2.8%
2.1% of portfolio
PEP
PepsiCo Inc.
-15.4%
0.3% of portfolio
PHM
Pulte Group Inc
-2.7%
1.6% of portfolio
FLO
Flowers Foods Inc
-9.5%
0.2% of portfolio
MSFT
Microsoft Corp
-0.4%
4.4% of portfolio

Sector Breakdown

Other42.6%
Healthcare15.1%
Technology14.0%
Financial9.5%
Industrial9.0%
Energy2.5%
Utilities2.3%
Communication2.0%

๐Ÿšช Exited Positionssold since Q3 2025

BIL
SPDR Bloomberg Barclays 1
SOLD
$234.1K
โ€”
Labcorp Holdings Inc
SOLD
$222.8K

Changes from Q3 2025

NEW4 new positions
โ†‘33 increased
โ†“23 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023